1. Home
  2. IE vs TSHA Comparison

IE vs TSHA Comparison

Compare IE & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ivanhoe Electric Inc.

IE

Ivanhoe Electric Inc.

HOLD

Current Price

$9.25

Market Cap

2.1B

ML Signal

HOLD

Logo Taysha Gene Therapies Inc.

TSHA

Taysha Gene Therapies Inc.

HOLD

Current Price

$6.21

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IE
TSHA
Founded
2020
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.8B
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
IE
TSHA
Price
$9.25
$6.21
Analyst Decision
Buy
Strong Buy
Analyst Count
3
8
Target Price
$18.17
$11.63
AVG Volume (30 Days)
2.3M
2.8M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
5.56
EPS
N/A
N/A
Revenue
$3,244,000.00
$9,773,000.00
Revenue This Year
$44.79
N/A
Revenue Next Year
$16.22
$1,152.42
P/E Ratio
N/A
N/A
Revenue Growth
11.82
17.28
52 Week Low
$8.50
$2.25
52 Week High
$21.55
$7.30

Technical Indicators

Market Signals
Indicator
IE
TSHA
Relative Strength Index (RSI) 30.81 52.09
Support Level N/A $6.11
Resistance Level $15.18 $6.76
Average True Range (ATR) 0.72 0.42
MACD -0.20 0.07
Stochastic Oscillator 2.23 49.86

Price Performance

Historical Comparison
IE
TSHA

About IE Ivanhoe Electric Inc.

Ivanhoe Electric Inc is a United States-based d minerals exploration company with a focus on developing mines from mineral deposits principally located in the United States. The company has four business segments; Santa Cruz Project; critical metals; data processing services; and energy storage. It derives a majority of its revenue from Canada. The Santa Cruz Project and critical metals segments are focused on mineral project exploration and development. The data processing segment provides data analytics, geophysical modeling, and artificial intelligence services for the mineral, oil & gas, and water exploration industries. The energy storage segment develops, manufactures, and installs vanadium flow batteries for grid-scale energy storage.

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a clinical-stage biotechnology company focused on advancing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system, or CNS. The company's clinical program TSHA-102 is in development for the treatment of Rett syndrome, a rare neurodevelopmental disorder with no approved disease-modifying therapies that address the genetic root cause of the disease. The Company views its operations and manages its business as a single operating segment, the gene therapy segment, which is the business of developing AAV-based gene therapies for the treatment of rare monogenic diseases of the central nervous system.

Share on Social Networks: